Evaluation of the therapeutic efficacy of tripeptide tyroserleutide (YSL) for human hepatocarcinoma by in vivo hollow fiber assay

Investigational New Drugs

Volumn 26, Issue 6, 2008, Pages 525-529

  Li, Xiao Lei ^a   Liu, Jun Yan ^a   Lu, Rong ^a,b   Xu, Qiong ^a   Zhu, Zhi Feng ^a   Wang, Li ^a   Zhou, Chun Lei ^a   Jia, Jing ^a   Fu, Zheng ^a   Yao, Zhi ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Shenzhen Kangzhe Pharmaceutical Co Ltd   (China)

Author keywords

Hepatocellular carcinoma; Hollow fiber assay (HFA); MTS; Tyroserleutide (YSL)

Indexed keywords

TRIPEPTIDE DERIVATIVE; TYROSERLEUTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASSAY; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HOLLOW FIBER; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; TUMOR MODEL;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; NEOPLASM TRANSPLANTATION; OLIGOPEPTIDES;

EID: 53749087561     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10637-008-9121-8     Document Type: Article

References (23)

1. HG Zhou GW Gu 1998 New tendency in clinical pathology of primary liver cancer Chinese Journal of Digestology 8 10 12
2. Z Yao R Lu J Jia P Zhao J Yang M Zheng J Lu M Jin H Yang W Gao 2006 The effect of tripeptide tyroserleutide (YSL) on animal models of hepatocarcinoma Peptides 27 1167 1172
3. MG Hollings head MC Alley RF Camalier BJ Abbott JG Mayo L Malspeis MR Grever 1995 In vivo cultivation of tumor cells in hollow fibers Life Sci 57 131 141
4. RM Chen DH Zhu XZ Ye 1975 The establishments and characteristic of human hepatocarcinoma cells BEL-7402 Chin Sci Bull 2 434 436
5. CR Dong RH Zhou DF Lv 1980 The establishment and biological characteristic of human hepatocarcinoma cells SMMC-7721 Academic Journal of Second Military Medical University 1 5 9
6. Knowles BB, Aden DP (1983) Human hepatoma derived cell line, process for preparation thereof, and uses therefore. US Patent: 4393133, 1983-07-12
7. BB Knowles CC Howe DP Aden 1980 Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen Science 209 497 499
8. SC Heffelfinger HH Hawkins J Barrish L Taylor GJ Darlington 1992 SK HEP-1: a human cell line of endothelial origin In Vitro Cell Dev Biol 28A 136 142
9. TM Buttke JA McCubrey TC Owen 1993 Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines J Immunol Methods 157 233 240
10. LA Hall CM Krauthauser RS Wexler MG Hollingshead AM Slee JS Kerr 2000 The hollow fiber assay: continued characterization with novel approaches Anticancer Res 20 903 911
11. JS Driscoll 1984 The preclinical new drug research program of the National Cancer Institute Cancer Treat Rep 68 63 76
12. RJ Kolberg 1990 Casting a wider net to catch cancer cures J NIH Res 2 82 84
13. M Suggitt MC Bibby 2005 50 years of preclinical anticancer drug screening: empirical to target-driven approaches Clin Cancer Res 11 971 981
14. M Monga EA Sausville 2002 Developmental therapeutics program at the NCI: molecular target and drug discovery process Leukemia 16 520 526
15. RS Gieni Y Li KT HayGlass 1995 Comparison of [3H]thymidine incorporation with MTT- and MTS-based bioassays for human and murine IL-2 and IL-4 analysis. Tetrazolium assays provide markedly enhanced sensitivity J Immunol Methods 187 85 93
16. R Everett 1984 Factors affecting spontaneous tumor incidence rates in mice: a literature review Crit Rev Toxicol 13 235 251
17. JP Levy JC Leclerc 1977 The murine sarcoma virus-induced tumor: exception or general model in tumor immunology? Adv Cancer Res 24 1 66
18. J Mattern M Bak EW Hahn M Volm 1988 Human tumor xenografts as model for drug testing Cancer Metastasis Rev 7 263 284
19. MA Webster WJ Muller 1994 Mammary tumorigenesis and metastasis in transgenic mice Semin Cancer Biol 5 69 76
20. LA Hall CM Krauthauser RS Wexler AM Slee JS Kerr 2003 The hollow fiber assay Methods Mol Med 74 545 566
21. SB Hassan M de la Torre P Nygren MO Karlsson R Larsson E Jonsson 2001 A hollow fiber model for in vitro studies of cytotoxic compounds: activity of the cyanoguanidine CHS 828 Anticancer Drugs 12 33 42
22. R Lu J Jia L Bao Z Fu G Li S Wang Z Wang M Jin W Gao Z Yao 2006 Experimental study of the inhibition of human hepatocarcinoma Bel7402 cells by the tripeptide tyroserleutide(YSL) Cancer Chemother Pharmacol 57 248 256
23. TP Xie XB Gu HL Zhu HG Ji 2005 High-throughput screening approaches for anticancer drugs in vivo-Hollow fiber assay Chinese Pharmaceutical Journal 40 469 470